Psychemedics

Psychemedics ROA

The Return on Assets (ROA) of Psychemedics (PMDI) as of Oct 16, 2026 is -22.37 %. In the previous year, Return on Assets (ROA) was -33.70 % — a change of -33.61% (higher).

ROA

-22.37 %

YoY

-33.61%

Last updated:

In 2024, Psychemedics's return on assets (ROA) was -22.37 %, a -33.61% increase from the -33.70 % ROA in the previous year.

The Psychemedics ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2017
23.09 USD
Jan 1, 2018
18.34 USD
Jan 1, 2019
5.59 USD
Jan 1, 2020
-16.08 USD
Jan 1, 2021
-3.09 USD
Jan 1, 2022
-5.79 USD
Jan 1, 2023
-33.70 USD
Jan 1, 2024
-22.37 USD
The Psychemedics ROA history
YEARROAYoY
-22.37 %-33.61%
-33.70 %+482.37%
-5.79 %+87.55%
-3.09 %-80.81%
-16.08 %-387.41%
5.59 %-69.50%
18.34 %-20.55%
23.09 %-13.50%
26.69 %+289.54%
6.85 %-48.61%
13.33 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Psychemedics Stock analysis

What does Psychemedics do? Psychemedics Corp, trading under the ticker PMDI, is a U.S.-based company headquartered in Acton, Massachusetts. The company specializes in drug testing services, focusing on the analysis of hair samples to detect the presence of drugs of abuse. With 204 full-time employees, Psychemedics operates within the Health Care sector, specifically in the Health Care industry. The company's primary service involves conducting drug tests and reporting results to clients, including training for sample collection and storage of positive samples for a fee per unit tested. Its testing methodology provides detailed information on the approximate amount of drug ingested and historical data on drug use patterns over time. Psychemedics went public on January 22, 1987, marking the beginning of its journey as a publicly traded entity. The company's website, https://www.psychemedics.com/, serves as a primary source of information for its services and operations. While the company's core business is centered on drug testing, it does not disclose specific product names or additional services beyond the scope of hair sample analysis and reporting. Psychemedics maintains a presence in the U.S. market, with its operations primarily focused on providing reliable and detailed drug testing solutions to its clients. The company's approach to testing emphasizes both the immediate detection of drug use and the ability to track usage patterns over extended periods, offering a comprehensive service for its customers. Psychemedics is one of the most popular companies on Eulerpool.

ROA Details

Understanding Psychemedics's Return on Assets (ROA)

Psychemedics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Psychemedics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Psychemedics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Psychemedics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Psychemedics stock

Return on Assets (ROA) of Psychemedics is -22.37 % in 2024.

Return on Assets (ROA) of Psychemedics changed from -33.70 % to -22.37 %, representing a -33.61% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Psychemedics since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Psychemedics with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Psychemedics

All Key Metrics — Psychemedics